Delivery Order SPE2DB25D3201-SPE2DB26FNNJY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,757.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes treatment medication commonly used within military and...
- The Defense Logistics Agency awarded a delivery order valued at $3,667.79 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on April 28, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by April 29, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used to improve blood sugar control in patients with type 2 diabetes,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens valued at $10,644.05 on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used within military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $10,343.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication widely used in federal healthcare systems, including...
- The Defense Logistics Agency awarded a $12,931.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price contract with no set-aside designation, reflecting a competitively awarded procurement. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used for treating type 2 diabetes,...
- The Defense Logistics Agency awarded a $6,044.85 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitive award uses firm fixed pricing with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a $2,366.00 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract is unset-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly supplied through federal medical procurement channels to support military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,016.73 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a branded diabetes medication used to improve blood sugar control in...
- The Defense Logistics Agency awarded a delivery order valued at $2,594.55 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on September 4, 2025, with completion targeted for September 5, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and federal healthcare systems...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on August 13, 2025, valued at $1,201.20 for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 14, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used to...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB26FNNJYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,408.40 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on October 16, 2025, with an ultimate completion date of October 17, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used in military and federal healthcare systems to manage type 2 diabetes. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. As a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, AmerisourceBergen has demonstrated significant capability in meeting federal procurement requirements through open competition, with a diversified portfolio spanning diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 10/16/25 |